Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,544 | 154 | 99.4% |
| Education | $21.00 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $781.02 | 35 | $0 (2024) |
| ABBVIE INC. | $466.66 | 20 | $0 (2024) |
| Lilly USA, LLC | $444.43 | 20 | $0 (2024) |
| Merck Sharp & Dohme LLC | $267.19 | 12 | $0 (2023) |
| Novo Nordisk Inc | $225.80 | 6 | $0 (2024) |
| Amgen Inc. | $225.52 | 6 | $0 (2024) |
| GlaxoSmithKline, LLC. | $209.09 | 11 | $0 (2024) |
| Amarin Pharma Inc. | $184.10 | 9 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $174.48 | 8 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $113.39 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,454 | 59 | ABBVIE INC. ($298.84) |
| 2023 | $1,185 | 57 | Teva Pharmaceuticals USA, Inc. ($300.11) |
| 2022 | $634.69 | 26 | Teva Pharmaceuticals USA, Inc. ($191.03) |
| 2021 | $291.69 | 13 | Merck Sharp & Dohme Corporation ($182.53) |
All Payment Transactions
155 individual payment records from CMS Open Payments — Page 3 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: Diabetes | ||||||
| 02/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.30 | General |
| Category: Cardiovascular | ||||||
| 02/20/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: Central Nervous System | ||||||
| 02/07/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $7.39 | General |
| Category: Central Nervous System | ||||||
| 01/29/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: NEUROSCIENCE | ||||||
| 01/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: NEUROSCIENCE | ||||||
| 01/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Inflammation | ||||||
| 01/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: Diabetes | ||||||
| 12/21/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $28.48 | General |
| Category: Diabetes | ||||||
| 12/19/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $29.81 | General |
| Category: Respiratory | ||||||
| 12/11/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: RESPIRATORY | ||||||
| 12/06/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: NEUROSCIENCE | ||||||
| 11/30/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.78 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Central Nervous System | ||||||
| 11/15/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Obesity | ||||||
| 11/06/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Inflammation | ||||||
| 10/31/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.86 | General |
| Category: Cardiovascular | ||||||
| 10/25/2023 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $22.26 | General |
| Category: Addiction Medicine | ||||||
| 10/24/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/18/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Diabetes | ||||||
| 10/11/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Diabetes | ||||||
| 10/05/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/27/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 268 | 474 | $69,284 | $30,951 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 73 | 172 | $35,365 | $16,064 | 45.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 164 | $25,148 | $11,223 | 44.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 20 | 20 | $4,156 | $2,521 | 60.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 40 | 50 | $1,075 | $416.50 | 38.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 21 | 21 | $1,033 | $384.30 | 37.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 27 | 27 | $1,947 | $277.68 | 14.3% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 17 | 20 | $560.00 | $64.20 | 11.5% |
About Jacob Levy, MS, FNP
Jacob Levy, MS, FNP is a Registered Nurse healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/17/2015. The National Provider Identifier (NPI) number assigned to this provider is 1710351515.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jacob Levy, MS, FNP has received a total of $3,565 in payments from pharmaceutical and medical device companies, with $1,454 received in 2024. These payments were reported across 155 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($3,544).
As a Medicare-enrolled provider, Levy has provided services to 268 Medicare beneficiaries, totaling 474 services with total Medicare billing of $30,951. Data is available for 1 year (2023–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Registered Nurse
- Other Specialties Family
- Location Brooklyn, NY
- Active Since 11/17/2015
- Last Updated 10/15/2018
- Taxonomy Code 163W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1710351515
Products in Payments
- Austedo XR (Drug) $412.69
- MOUNJARO (Drug) $386.90
- AUSTEDO (Drug) $302.77
- VRAYLAR (Drug) $300.66
- Otezla (Drug) $225.52
- BELSOMRA (Drug) $222.22
- TRELEGY ELLIPTA (Drug) $188.57
- Vascepa (Drug) $184.10
- Ozempic (Drug) $166.87
- SEGLENTIS (Drug) $113.39
- AIRSUPRA (Drug) $104.01
- UBRELVY (Drug) $94.40
- QULIPTA (Drug) $71.60
- BREZTRI (Drug) $70.47
- ELIQUIS (Drug) $70.09
- CAPLYTA (Drug) $66.33
- PAXLOVID (Drug) $63.58
- FREESTYLE LIBRE 3 (Device) $55.86
- Veozah (Drug) $46.26
- JANUVIA (Drug) $44.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Brooklyn
Dr. Kathleen Brooks, Nurse Practitioner, NURSE PRACTITIONER
Registered Nurse — Payments: $5,503
Alina Boshakova, Rn, RN
Registered Nurse — Payments: $3,716
Raisa Harrington, Pmhnp-Bc, PMHNP-BC
Registered Nurse — Payments: $3,665
Ashley Wu
Registered Nurse — Payments: $3,552
Victoria Liu, Np, NP
Registered Nurse — Payments: $3,090
Bernadette Dolce, Fnp, FNP
Registered Nurse — Payments: $3,048